Ant diabetics are the drugs which stabilize the glucose levels in blood. These medicines also control and lower the levels of glucose in blood for diabetic patients. Most common type of antidiabetics is insulin. A periodic shot of insulin generally long acting type is prescribed for diabetic patients to regulate glucose levels.
The global anti-diabetics market was valued at USD 100 million in 2024 and is expected to grow at a CAGR of more than 9.5% during the forecast period.
The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions.
The global antidiabetics market is segmented based on its product which include thiazolodinediones, glp-agonists, sulphonylureas, dpp-4 inhibitors, sglt-2, alpha-glucosidase inhibitors, biguanides and meglitinides. The insulin is segmented as rapid acting, long acting, premixed, premixed analog, short acting and intermediate acting. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW).
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sanofi-Aventis, Eli Lilly, Oramed Pharmaceuticals, Boehringer Ingelheim, Merck & Co. Inc., Bristol-Myers Squibb, Novo Nordisk, Halozyme Therapeutics, Pfizer and Takeda Pharmaceuticals. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/antidiabetics-market
Increasing number of diabetic patients is increasing the demand for antidiabetics which is a driving factor for antidiabetics market. Increased use of insulin is a growth factor for this market. Insulin leads the global market with the largest market share by revenue and anticipated to have sharp growth. Increase in rates of obesity is obliquely driving the antidiabetics market. North America hold the largest share in antidiabetics market as it holds highest rate of obesity in the world, which is one of the major reason for cause of diabetics.
This report provides:
1) An overview of the global market for antidiabetics and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for acetic acid market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The Antidiabetics Market has been segmented as below:
The Antidiabetics Market is Segmented on the lines of Types of Insulin, Product and Geography. By Types of Insulin this market is segmented on the basis of Rapid Acting, Long Acting, Premixed, Premixed Analog, Short Acting and Intermediate Acting.
By Product this market is segmented on the basis of Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors and Meglitinides. By Geography this market is segmented on the basis of North America, Europe,
Asia-Pacific and Rest of the World (ROW).
Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/antidiabetics-market
Table of Contents
- Executive Summary
- Antidiabetics Industry
- Antidiabetics Product
- Antidiabetics Regional
- Competitive Landscape
5.1 Sanofi Aventis
5.1.1 Company Overview
5.2 Takeda Pharmaceuticals
5.3 Eli Lilly
5.4 Oramed Pharmaceuticals Inc.
5.5 Merck & Co. Inc.
5.6 Novo Nordisk
5.7 Bristol-Myers Squibb
5.8 Halozyme Therapeutics
- Methodology and Scope
Other Related Market Research Reports:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States